Gastrin
Gastrin, Serum
Test
Method
Immunoassay
Report Includes
Specimens
Serum
Clinical Utility
For the diagnosis and monitoring of gastrin-secreting tumours, gastric ulcer, Zollinger-Ellison syndrome. Increased in pernicious anemia.
Test Location
Quest Diagnostics, California USA
Test Version
30-Sep-2019
Specimen
Specimens
Serum
Sample Volume
1 mL
Minimum Volume
0.5 mL
Patient Preparation
Fasting (12 h)
Collection & Handling
Collection Instructions
See Additional Information
Handling Information
Separate and freeze immediately. Store and send frozen.
Additional Information
Dietary supplements containing biotin may interfere in assays and may skew analyte results to be either falsely high or falsely low. For patients receiving the recommended daily doses of biotin, draw samples at least 8 hours following the last biotin supplementation. For patients on mega-doses of biotin supplements, draw samples at least 72 hours following the last biotin supplementation.
Stability
Ambient | Unacceptable |
---|---|
Refrigerated | Unacceptable |
Frozen | 28 days |
Additional Stability Information
If the specimen thaws, it is unsuitable for analysis.
Rejection Criteria
Specimen | Not frozen |
---|
Test Version
30-Sep-2019
Performance / Interpretation
Method
Immunoassay
Turnaround Time
5 days
Results
Name | Units | Reference Range | Conversion Factor | |
---|---|---|---|---|
Gastrin | pg/mL |
|
||
Test Location
Quest Diagnostics, California USA
Test Version
30-Sep-2019
Interface / Setup
HL7 Interface Codes
Order Code | Result Codes | Units |
---|---|---|
GASTRIN | 63038GASTRIN | pg/mL |
Test Version
30-Sep-2019